广发纳斯达克生物科技人民币(001092)

动态评分: 5.70分

投资组合

报告日期 名称 比例
2017-12-31 Alder BioPharmaceuticals Inc 0.1%
2017-12-31 CytomX Therapeutics Inc 0.1%
2017-12-31 Eagle制药 0.1%
2017-12-31 Intra-Cellular Therapies Inc 0.1%
2017-12-31 Intellia Therapeutics Inc 0.1%
2017-12-31 Travere Therapeutics Inc 0.1%
2017-12-31 Akebia Therapeutics Inc 0.09%
2017-12-31 ANI Pharmaceuticals Inc 0.09%
2017-12-31 多瓦制药 0.09%
2017-12-31 Insys Therapeutics Inc 0.09%
2017-12-31 MacroGenics Inc 0.09%
2017-12-31 PTC Therapeutics Inc 0.09%
2017-12-31 Vanda Pharmaceuticals Inc 0.09%
2017-12-31 Calyxt Inc 0.08%
2017-12-31 Collegium Pharmaceutical Inc 0.08%
2017-12-31 Five Prime Therapeutics Inc 0.08%
2017-12-31 uniQure NV 0.08%
2017-12-31 Atara Biotherapeutics Inc 0.07%
2017-12-31 Axon Enterprise Inc 0.07%
2017-12-31 Concert Pharmaceuticals Inc 0.07%

投资模拟

公告&资料